Abstract
INTRODUCTION
Pericyte platelet-derived growth factor receptor-β (PDGFR-β) signaling maintains neurovascular integrity, but its role in glymphatic function is unknown. We investigated whether pericyte PDGFR-β deficiency is associated with glymphatic dysfunction and altered aquaporin-4 (AQP-4) localization in Alzheimer’s disease (AD).
METHODS
Glymphatic trafficking was assessed by fluorescent cerebrospinal fluid (CSF) tracer injection. Meningeal lymphatic drainage was blocked by deep cervical lymph node (dcLN) ligation. Pericyte coverage, AQP-4 expression/localization, and basement membrane components were analyzed by immunofluorescence and western blot. Pericyte-conditioned medium was used to examine the effects of pericyte-derived factors on astrocytic AQP-4. The AQP-4 facilitator TGN-073 was administered to assess functional rescue. Blood–brain barrier integrity, microvascular density, and cerebral blood flow were also evaluated.
RESULTS
DcLN ligation impaired amyloid beta clearance and spatial memory. Both APP/PS1 and Pdgfr-β+/− mice exhibited pericyte loss and glymphatic dysfunction, with Pdgfr-β+/− mice additionally showing reduced perivascular AQP-4 expression, accompanied by decreased laminin-α2/β1. In vitro, pericyte-derived factors promoted AQP-4 expression. TGN-073 partially improved small-molecule CSF tracer distribution in Pdgfr-β+/− mice. Pdgfr-β+/−/APP/PS1 mice displayed exacerbated AD-like pathology.
DISCUSSION
PDGFR-β deficiency compromises basement membrane integrity and AQP-4 localization, impairing glymphatic transport and accelerating AD pathogenesis. The PDGFR-β pathway may represent a novel therapeutic target for enhancing waste clearance.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: | November 18, 2026
Neuro-Dementia